Current Drug Targets
Title:Meet the Editorial Board Member
Volume: 23 Issue: 2
Author(s): L. Zhang
Affiliation:
Export Options
About this article
Cite this article as:
Zhang L., Meet the Editorial Board Member, Current Drug Targets 2022; 23 (2) . https://dx.doi.org/10.2174/138945012302220118152057
DOI https://dx.doi.org/10.2174/138945012302220118152057 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
17
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
IL-6 and Crohns Disease
Current Drug Targets - Inflammation & Allergy Non Peptidic αvβ3 Antagonists: Recent Developments
Current Medicinal Chemistry The Role of Bacterial DNA in Inflammatory and Allergic Disease
Recent Patents on Inflammation & Allergy Drug Discovery Malignancy Risk in Systemic Lupus: Recent Research and Ongoing Challenges
Current Rheumatology Reviews TRAIL as Biomarker and Potential Therapeutic Tool for Cardiovascular Diseases
Current Drug Targets Ankylosing Spondylitis and Pregnancy: A Literature Review
Current Rheumatology Reviews Rheumatoid Arthritis: Notable Biomarkers Linking to Chronic Systemic Conditions and Cancer
Current Pharmaceutical Design The Potential of p38 MAPK Inhibitors to Modulate Periodontal Infections
Current Drug Metabolism Thalidomide in Multiple Myeloma
Current Pharmaceutical Biotechnology The Role of Wrist Fusion and Wrist Arthroplasty in Rheumatoid Arthritis
Current Rheumatology Reviews Cardiovascular Consequences of Autoimmune Rheumatic Diseases
Current Vascular Pharmacology Other Activities
Current Bioactive Compounds Extending the Clinical Horizons of Mucosal Bacterial Vaccines: Current Evidence and Future Prospects
Current Drug Targets Phenylpyazoleanilides as a Potent Inhibitor of IL-15 Dependent T Cell Proliferation. Part 1: A New Class of Orally Available Immunomodulators
Letters in Drug Design & Discovery Bone Disease - Current Knowledge and Future Prospects
Current Genomics Type 3 Diabetes Mellitus: A Novel Implication of Alzheimers Disease
Current Topics in Medicinal Chemistry Methotrexate: Should We Start Using it in Clinical Practice?
Current Drug Targets Biological Importance, Therapeutic Benefit and Analytical Aspects of Bioactive Flavonoid Pectolinarin in the Nature
Drug Metabolism Letters MicroRNAs and Lung Cancer: New Oncogenes and Tumor Suppressors, New Prognostic Factors and Potential Therapeutic Targets
Current Medicinal Chemistry Cardiovascular Adverse Effects of Anti-Inflammatory Drugs
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry